
About Sangon Biotech
Sangon Biotech is a Healthcare company based in Shanghai (China) founded in 2003. Research services, reagents, and kits for biotech applications are provided. Sangon Biotech has raised $300 million across 2 funding rounds from investors including CITIC Capital, Qiming Venture Partners and Greenwoods Investments. Its website sangon.com draws about 227 thousand monthly visits. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents.
Company details
Sangon Biotech was founded in 2003 and is based in Shanghai, China. Operations focus on the biotechnology sector, where services such as oligonucleotide, gene, and peptide synthesis are delivered. DNA and next-generation sequencing, along with protein, antibody, and molecular biology services, are also offered. Reagents including PCR and enzymes, plus ELISA and PCR kits, are supplied to support research activities.
- Headquarters Shanghai, China
- SectorsHealthcare
- Website category Science and Education · Biology
- Website sangon.com
- Social LinkedIn
- Total Equity Funding$300M (USD)
in 2 rounds
- Latest Funding Round$290M (USD), Series B
Apr 2023
- InvestorsCITIC Capital
& 7 more
Funding Insights of Sangon Biotech
Sangon Biotech has successfully raised a total of $300M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $290 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $300M
- Total Rounds 2
- Last Round Series B β $290M
- First Round $10M
(Aug 2010)
- Investors Count 8
All 2 funding rounds of Sangon Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2023 | $290M | Series B | β | Greenwoods Investments, Gl-investment | |
| Aug 2010 | $10M | Series A | β | β |
8 investors in total: 8 institutional.
Investors in Sangon Biotech
Sangon Biotech has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include CITIC Capital, Qiming Venture Partners and Greenwoods Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| greenwoodsinvest.com | ||||
Acquisitions are targeted by CPE as a private equity firm. | cpe-fund.com | Beijing, China | ||
Private equity investment firm focused on multiple sectors | huagaicapital.com | Dongguan, China | ||
Private equity and venture capital fund focused on the healthcare sector | novoholdings.dk | Hellerup, Denmark | ||
Venture capital investments are directed toward multiple sectors. | 2006 | qimingvc.com | Shanghai, China | |
GL Capital is focused on healthcare sector value investments. | gl-investment.com | Beijing, China | ||
| cdb-vc.com | ||||
Commercial ecological platform projects are targeted by this corporate fund. | 2002 | citiccapital.com | Hong Kong, China |
Investor details for Sangon Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Sangon Biotech
3 dated milestones of Sangon Biotech across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Sangon Biotech is founded.
- Funding First funding round of $10.0M.
- Funding Latest funding round, Series B, of $290.0M.
Web traffic of Sangon Biotech
The website of Sangon Biotech (sangon.com) receives about 226.9K visits a month and ranks #101,937 among all websites worldwide, #6,524 in Biology.
- Monthly visits226.9K
▼ 27.2% vs previous month
- Unique visitors75.9K
per month
- Global rank#101,937
among all websites
- Category rank#6,524
Science and Education · Biology
- Bounce rate33%
- Pages per visit7.7
- Average visit3 min 15 sec
- DevicesDesktop 61% Β· Mobile 39%
Websites whose visitors overlap most with Sangon Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
beyotime.com | beyotime.com | 100% | β | ||
| yeasen.com | 80% | 69K | #449,589 | View details | |
| sigmaaldrich.cn | 72% | #173,967 | View details | ||
medchemexpress.cn | medchemexpress.cn | 72% | #58,858 | β | |
takara.com.cn | takara.com.cn | 71% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Sangon Biotech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sangon Biotech
Complete news archive for Sangon Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sangon Biotech
Sangon Biotech was founded in 2003 and raised its 1st funding round 7 years after it was founded.
Sangon Biotech is headquartered in Shanghai, China.
Sangon Biotech is a funded company, having raised a total of $300M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Aug 2010.
Sangon Biotech was founded in 2003 and is based in Shanghai, China. Operations focus on the biotechnology sector, where services such as oligonucleotide, gene, and peptide synthesis are delivered. DNA and next-generation sequencing, along with protein, antibody, and molecular biology services, are also offered. Reagents including PCR and enzymes, plus ELISA and PCR kits, are supplied to support research activities.
Sangon Biotech has 8 investors. Key investors include CITIC Capital, Qiming Venture Partners, Greenwoods Investments, CPE, and GL Capital.
The website of Sangon Biotech receives about 227 thousand visits a month and ranks #101,937 among all websites worldwide.
